Exact Mass: 469.1406452000001

Exact Mass Matches: 469.1406452000001

Found 32 metabolites which its exact mass value is equals to given mass value 469.1406452000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

RO4929097

RO4929097

C22H20F5N3O3 (469.142475)


D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

O-Methyl-4-[(2',3',4'-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate

(2S,3S,4R,5R,6S)-4,5-bis(acetyloxy)-6-(4-{[(methoxymethanethioyl)amino]methyl}phenoxy)-2-methyloxan-3-yl acetate

C21H27NO9S (469.1406452000001)


O-Methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate is a fully acetylated thiocarbamate glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans and cis rotamers differ in the orientation of the NH group with respect to sulfur.

   

Bucladesine

[6-[6-(Butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-D][1,3,2]dioxaphosphinin-7-yl] butanoic acid

C18H24N5O8P (469.1362434)


   

Oxaprozin glucuronide

6-{[3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C24H23NO9 (469.1372748)


   

RO4929097

N-{9-hydroxy-8-azatricyclo[9.4.0.0,]pentadeca-1(15),2,4,6,8,11,13-heptaen-10-yl}-2,2-dimethyl-N-(2,2,3,3,3-pentafluoropropyl)propanediimidate

C22H20F5N3O3 (469.142475)


D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators

   

O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (E)|O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (Z)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (E)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (Z)

O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (E)|O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (Z)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (E)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (Z)

C21H27NO9S (469.1406452000001)


   

Bucladesine

[(4aR,7R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate

C18H24N5O8P (469.1362434)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CE - Phosphodiesterase inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

fmoc-(s)-3-amino-4-(2-trifluoromethyl-phenyl)-butyric acid

fmoc-(s)-3-amino-4-(2-trifluoromethyl-phenyl)-butyric acid

C26H22F3NO4 (469.15008480000006)


   
   

Fmoc-(S)-3-Amino-4-(4-trifluoromethylphenyl)-butyric acid

Fmoc-(S)-3-Amino-4-(4-trifluoromethylphenyl)-butyric acid

C26H22F3NO4 (469.15008480000006)


   

Fmoc-(R)-3-Amino-4-(2-trifluoromethylphenyl)-butyric acid

Fmoc-(R)-3-Amino-4-(2-trifluoromethylphenyl)-butyric acid

C26H22F3NO4 (469.15008480000006)


   

Fmoc-(R)-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid

Fmoc-(R)-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid

C26H22F3NO4 (469.15008480000006)


   

Fmoc-(S)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid

Fmoc-(S)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid

C26H22F3NO4 (469.15008480000006)


   

Fmoc-(R)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid

Fmoc-(R)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid

C26H22F3NO4 (469.15008480000006)


   

2-(2-phenyl-9H-carbazol-9-yl)dibenzo[b,d]thiophen-4-ylboronic acid

2-(2-phenyl-9H-carbazol-9-yl)dibenzo[b,d]thiophen-4-ylboronic acid

C30H20BNO2S (469.13077300000003)


   

4-[(4-Chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt

4-[(4-Chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt

C24H24ClN3O5 (469.14044040000005)


   

Sofpironium bromide

Sofpironium bromide

C22H32BrNO5 (469.14637220000003)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent Sofpironium bromide (BBI 4000) is an anticholinergic agent used in the study of primary axillary hyperhidrosis (PAH). Sofpironium bromide reduces sweating by inhibiting M3 muscarinic receptors in eccrine glands at the application site. Sofpironium bromide also has a high afnity for the M1, M2, M4 and M5 subtypes[1].

   
   

3-fluoro-N-[4-[[4-(4-methoxyphenyl)-1-piperazinyl]-oxomethyl]phenyl]benzenesulfonamide

3-fluoro-N-[4-[[4-(4-methoxyphenyl)-1-piperazinyl]-oxomethyl]phenyl]benzenesulfonamide

C24H24FN3O4S (469.14714760000004)


   

3-(4-{2-[2-(2-Bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid

3-(4-{2-[2-(2-Bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid

C19H27N5O5S2 (469.1453532)


   
   

6-[3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C24H23NO9 (469.1372748)


   

7-(4-chlorophenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylic acid 2-methoxyethyl ester

7-(4-chlorophenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylic acid 2-methoxyethyl ester

C26H25ClFNO4 (469.14560520000003)


   

10-(2-Amino-ethylamino)-9-(3-chloro-phenyl)-2,2,5-trimethyl-1,4-dihydro-2H,9H-3-oxa-7-thia-6,9,11-tria za-benzo[c]fluoren-8-one

10-(2-Amino-ethylamino)-9-(3-chloro-phenyl)-2,2,5-trimethyl-1,4-dihydro-2H,9H-3-oxa-7-thia-6,9,11-tria za-benzo[c]fluoren-8-one

C23H24ClN5O2S (469.13391540000003)


   

butanoic acid [(4aS,5R,6R,7aR)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester

butanoic acid [(4aS,5R,6R,7aR)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester

C18H24N5O8P (469.1362434)


   

2-methoxyethyl (4S,7S)-7-(4-chlorophenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate

2-methoxyethyl (4S,7S)-7-(4-chlorophenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate

C26H25ClFNO4 (469.14560520000003)


   

[(4aR,5R,6R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphinin-5-yl] butanoate

[(4aR,5R,6R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphinin-5-yl] butanoate

C18H24N5O8P (469.1362434)


   

butanoic acid [(4aS,6S,7S,7aS)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-yl] ester

butanoic acid [(4aS,6S,7S,7aS)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-yl] ester

C18H24N5O8P (469.1362434)


   

(4-Methoxybenzyl)thiocarbamic acid 4-O-(tri-O-acetyl-alpha-L-rhamnopyranoside)

(4-Methoxybenzyl)thiocarbamic acid 4-O-(tri-O-acetyl-alpha-L-rhamnopyranoside)

C21H27NO9S (469.1406452000001)


   
   
   

10-Formylfolic acid

(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methyl-formylamino]benzoyl]amino]pentanedioic acid

C20H19N7O7 (469.1345904)


-